# Deflazacort Oral Suspension

NDC: 27808-249
Generic name: Deflazacort Oral
Labeler / Manufacturer: Cranbury Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20240501

FDA application: ANDA217813

## Active ingredients

- DEFLAZACORT: 22.75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27808-249"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27808-249
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=881785a5-41b4-4679-a29b-5d77ca51ca60